Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Audrey Cras(Délégation Paris 7), Lingyun Sun(Anhui Medical University), Dominique Farge(Hôpital Saint-Louis), Jean‐Jacques Lataillade(Hôpital d'instruction des Armées Percy), T. Carmoi(Service de Santé des Armées), Dan Wang(Tianjin University of Traditional Chinese Medicine)
Cited by 83
Related Papers
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II
|Journal of Biological Chemistry|2000|450
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396